PMID: 11315344Apr 24, 2001Paper

Azathioprine therapy for patients with systemic lupus erythematosus

Lupus
M Abu-Shakra, Y Shoenfeld

Abstract

Azathioprine is the only purine analog that is widely used for the management of systemic lupus erythematosus (SLE). For SLE patients without renal involvement, it is given to those patients who require a maintenance dose of 15 mg or higher of prednisone and for those who experience recurrent flares. Azathioprine in combination with steroids may be given to a large number of patients with lupus nephritis. It is also effective for patients with skin lesions, pneumonitis, thrombocytopenia or hemolytic anemia. Azathioprine may be used during pregnancy but not during lactation. It has not been shown to increase the risk for the development of malignancies among patients with SLE.

Citations

May 29, 2008·European Journal of Clinical Pharmacology·Srikumar SahasranamanSandip Roy
Apr 8, 2006·Journal of the Chinese Medical Association : JCMA·Ming-Jie YangHsiao-Yi Lin
Dec 2, 2004·Nature Reviews. Drug Discovery·Joan T MerrillJill P Buyon
Apr 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maria Angeles RamosManuel Arias
Sep 9, 2010·Rheumatology·Alastair L HepburnJustin C Mason
May 1, 2002·Current Opinion in Rheumatology·Daniel J Wallace
Apr 19, 2002·Paediatric Drugs·Luis CarreñoIndalecio Monteagudo
Jun 3, 2014·La Presse médicale·Pamela M K LutaloDavid P D'Cruz
Apr 20, 2011·Current Rheumatology Reports·Alana B Levine, Doruk Erkan
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Paul Hasler, Moncef Zouali
Jul 1, 2005·Expert Review of Clinical Immunology·Gisele Zandman-GoddardYehuda Shoenfeld
Dec 22, 2006·Expert Review of Neurotherapeutics·Simone FerreroNicola Ragni
Jul 7, 2015·Expert Review of Clinical Pharmacology·Xiaoyan YangAlexander A Vinks
Mar 11, 2005·Expert Opinion on Emerging Drugs·Joan T Merrill
Oct 27, 2006·Expert Opinion on Emerging Drugs·Chi Chiu Mok
Jan 1, 2008·Toxicology Mechanisms and Methods·T S ShanmugarajanV Ravichandiran
Nov 6, 2010·Primary Care·Joseph P Michalski, Charles Kodner
Aug 8, 2009·British Journal of Clinical Pharmacology·Shirley Kow Yin KhamAllen Eng Juh Yeoh
Nov 16, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Joerg WenzelThomas Tüting
Jul 3, 2009·American Journal of Ophthalmology·Sirichai PasadhikaEric B Suhler
Nov 17, 2009·Biochimica Et Biophysica Acta·Greg HertingNicholas E Burgis
Jan 28, 2014·Autoimmunity Reviews·Christopher Chang
Mar 24, 2016·Case Reports in Rheumatology·Khalid Hamid ChangalAb Hameed Raina
Oct 26, 2016·Journal of Autoimmunity·Alba Velo-GarcíaDavid A Isenberg
Nov 19, 2004·Springer Seminars in Immunopathology·Richard K BurtShimon Slavin
Nov 8, 2013·The Open Rheumatology Journal·Fozya Bashal
May 5, 2020·Alimentary Pharmacology & Therapeutics·Albert J Czaja
Oct 14, 2017·Rheumatology·Caroline GordonUNKNOWN British Society for Rheumatology Standards, Audit and Guidelines Working Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.